iRhythm Technologies (IRTC) to Release Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Thursday, February 20th. Analysts expect the company to announce earnings of ($0.29) per share and revenue of $158.02 million for the quarter. Parties interested in listening to the company's conference call can do so using this link.

iRhythm Technologies Trading Down 0.1 %

IRTC traded down $0.08 during mid-day trading on Friday, hitting $112.11. The stock had a trading volume of 223,305 shares, compared to its average volume of 447,135. The stock's fifty day simple moving average is $99.07 and its 200-day simple moving average is $82.41. The company has a debt-to-equity ratio of 9.00, a current ratio of 6.27 and a quick ratio of 6.12. The firm has a market capitalization of $3.51 billion, a price-to-earnings ratio of -23.07 and a beta of 1.29. iRhythm Technologies has a 1-year low of $55.92 and a 1-year high of $124.11.

Insider Buying and Selling at iRhythm Technologies

In other news, insider Patrick Michael Murphy sold 2,492 shares of iRhythm Technologies stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $85.89, for a total value of $214,037.88. Following the completion of the transaction, the insider now owns 35,327 shares of the company's stock, valued at $3,034,236.03. This trade represents a 6.59 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.68% of the company's stock.

Analyst Ratings Changes

IRTC has been the topic of several analyst reports. Oppenheimer increased their target price on shares of iRhythm Technologies from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Wednesday, January 8th. Needham & Company LLC raised their price objective on shares of iRhythm Technologies from $96.00 to $112.00 and gave the stock a "buy" rating in a report on Monday, January 13th. Wells Fargo & Company restated an "equal weight" rating and set a $86.00 price objective on shares of iRhythm Technologies in a report on Tuesday, December 3rd. Truist Financial raised their price objective on shares of iRhythm Technologies from $85.00 to $111.00 and gave the stock a "buy" rating in a report on Wednesday, December 18th. Finally, Robert W. Baird dropped their price objective on shares of iRhythm Technologies from $100.00 to $79.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $108.45.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.